Real World Evidence: Can We Really Expect It to Have Much Influence?
- Published in:
- 2019
- By:
- Publication type:
- Editorial
Works matching IS 21989788 AND DT 2019 AND VI 6 AND IP 2
Results: 5
1
2
Prevalence of Psychotropic Polypharmacy and Associated Healthcare Resource Utilization during Initial Phase of Care among Adults with Cancer in USA.
- Published in:
- Drugs - Real World Outcomes, 2019, v. 6, n. 2, p. 73, doi. 10.1007/s40801-019-0153-5
- By:
- Publication type:
- Article
3
A Benefit Risk Review of Pediatric Use of Hydrocodone/Chlorpheniramine, a Prescription Opioid Antitussive Agent for the Treatment of Cough.
- Published in:
- Drugs - Real World Outcomes, 2019, v. 6, n. 2, p. 47, doi. 10.1007/s40801-019-0152-6
- By:
- Publication type:
- Article
4
Adverse Events Associated with Risperidone Use in Pediatric Patients: A Retrospective Biobank Study.
- Published in:
- Drugs - Real World Outcomes, 2019, v. 6, n. 2, p. 59, doi. 10.1007/s40801-019-0151-7
- By:
- Publication type:
- Article
5
A Pilot Study to Assess the Feasibility of a Web-Based Survey to Examine Patient-Reported Symptoms and Satisfaction in Patients with Ankylosing Spondylitis Receiving Secukinumab.
- Published in:
- Drugs - Real World Outcomes, 2019, v. 6, n. 2, p. 83, doi. 10.1007/s40801-019-0154-4
- By:
- Publication type:
- Article